Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thoracic Neoplasms × Ultrasonography × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Prostatic Neoplasms 7 Neoplasms 4 Thyroid Nodule 3 Squamous Cell Carcinoma of Head and Neck 3 Sarcopenia 3 Rectal Neoplasms 3 Polycystic Ovary Syndrome 3 Pancreatic Neoplasms 3 Mouth Neoplasms 3 Liver Neoplasms 3 Liver Cirrhosis 3 Endometrial Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Tongue Neoplasms 2 Thyroid Neoplasms 2 Ovarian Neoplasms 2 Ovarian Cysts 2 Lung Neoplasms 2 Hypersensitivity 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Uveal Melanoma 1 Urologic Neoplasms 1 Urethral Neoplasms 1 Thrombosis 1 Thoracic Neoplasms 1

Interventions

Carboplatin 12 Pemetrexed 6 pembrolizumab 5 Paclitaxel 5 osimertinib 4 atezolizumab 4 entinostat 3 durvalumab 3 Erlotinib Hydrochloride 3 Cisplatin 3 selpercatinib 2 pralsetinib 2 camrelizumab 2 apatinib 2 Radiosurgery 2 Injections 2 Bevacizumab 2 130-nm albumin-bound paclitaxel 2 toripalimab 1 taletrectinib 1 sotorasib 1 sintilimab 1 repotrectinib 1 pegylated granulocyte colony-stimulating factor 1 patritumab 1 napabucasin 1 ficlatuzumab 1 exemestane 1 efineptakin alfa 1 cobimetinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05321615 2023-10-25

Palpator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Unknown

Lung Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡